Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]


Angiogenesis is the process of growth and formation of new blood vessels in cancer. It is a defining factor that determines the transformation of cells from benign to a malignant state. Chemical signals from tumors regulate angiogenesis, promoting increase in blood supply, and oxygen to the tumor microenvironment, facilitating its aggressive progression.  Pharmaceutical companies have approached this subject by investigating on the use of angiogenesis inhibitors to cure cancer.
With our broad range of recombinant proteins, antibodies, assay kits to these angiogenic factors like VEGF, PDGF, TNF-alpha, TGF-alpha and many more, BioVision is helping to advance research in this area.